Interferon-γ is required for lupus nephritis in mice treated with the hydrocarbon oil pristane

Kidney International

Volumn 60, Issue 6, 2001, Pages 2173-2180

  Richards, Hanno B ^a,b   Satoh, Minoru ^a,b   Jennette, J Charles ^a,b   Croker, Byron P ^a,b   Yoshida, Hideo ^a,b   Reeves, Westley H ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Antinuclear antibodies; Glomerulonephritis; Immune complex disease; Pristane; Systemic lupus erythematosus

Indexed keywords

DNA ANTIBODY; GAMMA INTERFERON; HYDROCARBON; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; INTERLEUKIN 4; PRISTANE; RIBONUCLEOPROTEIN ANTIBODY; SINGLE STRANDED DNA; SMOOTH MUSCLE ANTIBODY; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; CAPILLARY; CHROMATIN; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; FEMALE; GLOMERULUS; HEREDITY; IMMUNE COMPLEX DEPOSITION; IMMUNOFLUORESCENCE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN PRODUCTION; KIDNEY; KIDNEY DISEASE; LUPUS ERYTHEMATOSUS NEPHRITIS; MICROSCOPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; SEROLOGY; TH1 CELL; TH2 CELL;

EID: 0035182394     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2001.00045.x     Document Type: Article

References (46)

1. Systemic lupus erythematosus: Prototype of immune complex disease in man
2. Polynucleotide immune complexes in serum and glomeruli of patients with systemic lupus erythematosus
3. Anti-DNA antibodies bind directly to renal antigens and induce kidney dysfunction in the isolated perfused rat kidney
4. Nephritogenic autoantibodies in lupus: Current concepts and continuing controversies
5. Murine glomerulotropic monoclonal antibodies are highly oligoclonal and exhibit distinctive molecular features
6. Modulation of renal disease in autoimmune NZB/NZW mice by immunization with bacterial DNA
7. Polygenic control of susceptibility to murine systemic lupus erythematosus
8. Renal involvement in systemic lupus erythematosus (SLE): A study of 56 patients emphasizing histologic classification
9. Renal involvement in systemic lupus erythematosus. A study of 180 patients from a single center
10. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains
11. Induction of lupus-associated autoantibodies in BALB/c mice by intraperitoneal injection of pristane
12. Widespread susceptibility among inbred mouse strains to the induction of lupus auto-antibodies by pristane
13. Autoantibodies to ribosomal P antigens with immune complex glomerulonephritis in SJL mice treated with pristane
14. Antinuclear antibody production and immune complex glomerulonephritis in BALB/c mice treated with pristane
15. Elevated interleukin 6 is induced by prostaglandin E2 in a murine model of inflammation: Possible role of cyclooxgenase-2
16. Antinuclear autoantibodies and lupus nephritis in transgenic mice expressing interferon gamma in the epidermis
17. Interleukin-4 expression in mesangial proliferative glomerulonephritis
18. Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of interleukin-10: Interferon-gamma-secreting cells in the peripheral blood
19. IL-6 dependence of anti-DNA antibody production: Evidence for two pathways of autoantibody formation in pristane-induced lupus
20. Roles of interferon-gamma and interleukin-4 in murine lupus
21. IFN-gamma is essential for the development of autoimmune glomerulonephritis in MRL/lpr mice
22. lpr mice
23. Disparate T cell requirements of two subsets of lupus-specific autoantibodies in pristane-treated mice
24. Pristane induces high titers of anti-Su and anti-nRNP/Sm autoantibodies in BALB/c mice. Quantitation by antigen capture ELISAs based on monospecific human autoimmune sera
25. Disruption of the murine IL-4 gene blocks Th2 cytokine responses
26. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes
27. Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus
28. Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production
29. Impaired production of IL-12 in systemic lupus erythematosus. I. Excessive production of IL-10 suppresses production of IL-12 by monocytes
30. Constitutive expression of interleukin (IL)-4 in vivo causes autoimmune-type disorders in mice
31. Interleukin-4 protects against a genetically linked lupus-like autoimmune syndrome
32. Experimental therapy of systemic lupus erythematosus: The treatment of NZB/W mice with mouse soluble interferon-gamma receptor inhibits the onset of glomerulonephritis
33. Crescentic glomerulonephritis in interferon-gamma receptor deficient mice
34. Lipopolysaccharide-induced glomerulonephritis develops in the absence of interferon-gamma signaling
35. 4-mediated disease
36. Increased interferon-gamma (IFN-gamma), IL-10 and decreased IL-4 mRNA expression in peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE)
37. Th1/Th2 balance of peripheral T helper cells in systemic lupus erythematosus
38. Treatment of chronic hepatitis C with recombinant interferon alfa
39. Possible induction of systemic lupus erythematosus by interferon-alpha treatment in a patient with a malignant carcinoid tumour
40. Hydrocarbons may worsen renal function in glomerulonephritis: A meta-analysis of the case-control studies
41. Humoral immune functions in IL-4 transgenic mice
42. Preferential activation of Th2 cells in chronic graft- versus-host reaction
43. Interferon-gamma is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice
44. IFN-gamma receptor deletion prevents autoantibody production and glomerulonephritis in lupus-prone (NZB X NZW)F1 mice
45. Fas and Fas ligand mutations inhibit autoantibody production in pristane-induced lupus
46. Lupus-like autoimmune disease induced by interferon therapy for myeloproliferative disorders